GoodRx Holdings, Inc. (GDRX) Stock Score, Valuation & Financial Research
GoodRx Holdings, Inc. is in the Healthcare sector and Medical - Healthcare Information Services industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 33/100.
Quick answer for GDRX
GoodRx Holdings, Inc. currently has a Wall Street Score of 33/100. The stored market price is $3.39. Its financial score is 29/100. Its valuation score is 0/100. The latest WSS change is -0.4 points. These figures are a research snapshot, not a buy or sell recommendation.
What GoodRx Holdings, Inc. does
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was
GDRX financial snapshot
- Wall Street Score:
- 33/100
- Current price:
- $3.39
- Market capitalization:
- $1.18B
- Revenue:
- $785.2M
- Net income:
- $16.2M
- Free cash flow:
- $164.4M
- Cash:
- $296.1M
- Total debt:
- $539.0M
- EPS:
- 0.05
- P/E ratio:
- 64.4x
- Financial score:
- 29/100
- Valuation score:
- 0/100
- Revenue score:
- 11/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $164.4M, showing positive cash generation.
- The balance sheet shows $296.1M of cash versus $539.0M of total debt, so leverage deserves attention.
- The latest Wall Street Score change is -0.4 points: GDRX decreased 0.4 points because Valuation declined by 3.8 points.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 29/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-04.
How to research GDRX
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.